Table 1. CD80 and CD86 expression by... | American Society of Hematology

Table 1.

CD80 and CD86 expression by BCP-ALL cells activated or not activated with CD40L

	Positive cells, %
	CD80			CD86
Patient	-CD40L	+CD40L	-CD40L	+CD40L
1	3	10	7	15
2	0	0	0	10
3	5	25	34	55
4	0	0	80	90
5	9	20	64	78
6	0	20	20	40
7	0	5	50	60
8	18	44	27	45
9	0	0	0	5
10	15	52	30	70
11	50	70	60	70
12	20	68	22	68
13	30	40	58	70
14	0	8	10	35
15	70	90	70	94
16	30	30	60	72
17	0	15	20	40
18	0	0	0	5
19	0	30	25	60

	Positive cells, %
	CD80			CD86
Patient	-CD40L	+CD40L	-CD40L	+CD40L
1	3	10	7	15
2	0	0	0	10
3	5	25	34	55
4	0	0	80	90
5	9	20	64	78
6	0	20	20	40
7	0	5	50	60
8	18	44	27	45
9	0	0	0	5
10	15	52	30	70
11	50	70	60	70
12	20	68	22	68
13	30	40	58	70
14	0	8	10	35
15	70	90	70	94
16	30	30	60	72
17	0	15	20	40
18	0	0	0	5
19	0	30	25	60

BCP-ALL cells were cocultured on HBMS in the presence or absence of CD40L transfectants. After 48 hours, the cells were stained with FITC-conjugated mAbs. Phenotypic analysis was performed on the gated cells to exclude cell debris. Results are expressed as percentage of positive cells.

View Large

This Feature Is Available To Subscribers Only